GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Phathom Pharmaceuticals: Potential Blockbuster Gastric Acid-Reducing Drug With New Mechanism Jun. 25, 2025 4:54 AM ET Phathom Pharmaceuticals, Inc. (PHAT) Stock PHAT 5 Comments Bhavneesh Sharma ...

On the basis of phase 2 studies, trastuzumab deruxtecan was approved for patients with human epidermal growth factor receptor 2 (HER2)–positive metastatic gastric cancer or gastroesophageal ...

Background: Idiopathic gastroparesis is a syndrome characterised by severely delayed gastric emptying of solids without an obvious underlying organic cause. Although delayed gastric emptying is ...

SYNT-101 is a once-daily pill designed to mimic the effects of gastric bypass surgery while preserving lean muscle mass better than other weight loss drugs. New Africa – stock.adobe.com “We ...

Where a gastric tumor first develops defines its anatomic classification as cardia or non-cardia. Other types of stomach cancer include carcinoid, small cell carcinoma, and squamous cell carcinoma.

Diagnosing gastroparesis often involves a gastric emptying scintigraphy test to measure how fast food moves through the stomach.

What is SADI-S? New surgery leads to more weight loss than gastric bypass and Ozempic By McKenzie Beard Published March 26, 2025, 3:51 p.m. ET ...

Asano, T., Aida, S., Suemasu, S., Tahara, K., Tanaka, K. and Mizushima, T. (2015) Aldioxa Improves Delayed Gastric Emptying and Impaired Gastric Compliance, Pathophysiologic Mechanisms of Functional ...

Engineers designed a new type of gastric balloon that can be inflated and deflated as needed. It could offer an alternative for people who don't want to undergo more invasive treatments such ...